Granted Patent
B2
US 12,416,007 · App. 18/199,817 · Granted Sep 16, 2025
GATA3 inhibitors for treating insulin resistance
Assignee:
QATAR UNIVERSITY
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Methods and compositions using dnayzme-based GATA3 inhibitors for the treatment of insulin resistance and Type II diabetes, for the stimulation of adipogenesis in vivo, and for the promotion of fat redistribution are disclosed.
Claims (10)
1. A method of reducing insulin resistance in an individual in need thereof by inhibiting GATA3 expression, wherein the GATA3 expression is inhibited by administering to the subject an effective amount of a dnazyme having an oligonucleotide sequence selected from any one of SEQ ID NOs: 1-151.
2. The method of claim 1 , wherein the dnazyme is hgd40 having an oligonucleotide sequence of SEQ ID NO:1.
3. The method of claim 1 , wherein the individual is a mammal.
4. The method of claim 3 , wherein the mammal is a human.
5. The method of claim 4 , wherein the human is suffering from insulin resistance or Type II diabetes.
6. The method of claim 1 , wherein the administering of the GATA3 inhibitor to the subject comprises increasing expression of IL-10 gene and decreasing expression of IL-6, PAI-I, resistin, and glucagon genes in the subject.
7. A method of reducing impaired adipogenesis in a subject in need thereof by inhibiting GATA3 expression, wherein the GATA3 expression is inhibited by administering to the subject an effective amount of a dnazyme having an oligonucleotide sequence selected from any one of SEQ ID NOs: 1-151.
8. The method of claim 7 , wherein the dnazyme is hgd40 having an oligonucleotide sequence of SEQ ID NO:1.
9. The method of claim 7 , wherein the patient is a mammal.
10. The method of claim 9 , wherein the mammal is a human.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 17, 2024
From: ELRAYESS, MOHAMED, DR; ALMANSOORI, LAYLA
To: QATAR UNIVERSITY
Reel/Frame 066151/0446 →
Continuity (2)
References Cited (146)
US 8119789B2
· Sel et al.
· 2012
[cited by applicant]
US 9249413B2
· Schmidts et al.
· 2016
[cited by applicant]
US 9404110B2
· Schmidts et al.
· 2016
[cited by applicant]
US 9417243B2
· Qi et al.
· 2016
[cited by applicant]
US 9428576B2
· Tacha et al.
· 2016
[cited by applicant]
US 9797888B2
· Akitomi et al.
· 2017
[cited by applicant]
US 20070166710A1
· Stoffel et al.
· 2007
[cited by applicant]
US 20150216892A1
· Thibonnier
· 2015
[cited by applicant]
US 20170298361A1
· Shaul et al.
· 2017
[cited by applicant]
WO 2005124359A2
· 2005
[cited by applicant]
WO 2019217423A1
· 2019
[cited by applicant]
Hotamisligil, et al: “Adipose expression of tumor necrosis factor-a: Direct role in obesity-linked insulin resistance”, Science; Jan. 1, 1993; vol. 259, pp. 87-91.
[cited by applicant]
Hu, et al: “Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation”, Phytomedicine 2009; vol. 16, pp. 864-873.
[cited by applicant]
Hu, et al: “Berberine inhibits adipogenesis in high-fat diet-induced obesity mice”, Fitoterapia 2010; vol. 81, pp. 358-366.
[cited by applicant]
Huda, et al: “Genetic variation of the transcription factor GATA3, not STAT4, is associated with the risk of type 2 diabetes in the Bangladeshi population”, PLOS One; Jul. 25, 2018; vol. 13(7), e0198507.
[cited by applicant]
Jack, et al: “GATA proteins work together with friend of GATA (FOG) and C-terminal binding protein (CTBP) co-regulators to control adipogensis”, The Journal of Biological Chemistry; Oct. 15, 2010; vol. 285(42), pp. 3240…
[cited by applicant]
Jaganjac, et al: “Combined metformin and insulin treatment reverses metabolically impaired omental adipogenesis and accumulation of 4-hydroxynonenal in obese diabetic patients”, Redox Biology; Mar. 16, 2017; vol. 12, pp…
[cited by applicant]
Ji, et al: “Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T Cells and Interleukin-4”, The Journal of Biological Chemistry; Jul. 13, 2012; vol. 287(2…
[cited by applicant]
Jo, et al: “Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth”, PLOS Computational Biology; Mar. 27, 2009; vol. 5(3), e1000324; doi:10/371/journal.pcbi.1000324.
[cited by applicant]
Joulin, et al: “A T Cell specific TCR & DNA binding protein is a member of the human GATA family”, The EMBO Journal 1991; vol. 10(7), pp. 1809-1816.
[cited by applicant]
Kahn, et al: “Mechanisms linking obesity to insulin resistence and type 2 diabetes”, Nature Insight Review; Dec. 14, 2006; vol. 444, pp. 840-846; doi:10.1038/nature05482.
[cited by applicant]
Karri, et al: “Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective”, Biomedicine & Pharmacotherapy 2019; vol. 110, pp. 224-238.
[cited by applicant]
Khan, et al: “Metabolic dysregulation and adipose tissue fibrosis: Roel of collagen VI”, Molecular and Cellular Biology; Mar. 2009; vol. 29(6), pp. 1575-1591.
[cited by applicant]
Kim, et al: “Identification of Creb314 as an essential negative regulator of adipogenesis”, Cell Death and Disease 2014; vol. 5(e), pp. 1-13.
[cited by applicant]
King, et al: “Global burden of diabetes 1995-2025 Prevalence, numberical estimates, and projections”, Diabetes Care, Sep. 9, 1998; vol. 21(9), pp. 1414-1431.
[cited by applicant]
King, et al: “The role of inflammatory cytokines in diabetes and its complications”, The Journal of Periodontology; Aug. 1, 2008; vol. 79(8S), pp. 1527-1534.
[cited by applicant]
Ko, et al: “DNA-Binding specificities of the GATA transcription factor family”, Molecular and Cellular Biology, Jul. 1993; vol. 13(7), pp. 4011-4022.
[cited by applicant]
Kopelman: “Obesity as a medical problem”, Insight Review Article, Nature; Apr. 6, 2000; vol. 404, pp. 635-643.
[cited by applicant]
Krause, et al: “Quantitative assessment of adipocyte differentiation in cell culture”, Adipocyte 2016; vol. 5(4), pp. 352-358.
[cited by applicant]
Lee, et al: “Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications”, Molecular Aspects of Medicine; Oct. 13, 2012; vol. 34, pp. 1-11.
[cited by applicant]
Li, et al: “Bio-informatics analysis of a gene co-expression module in adipose tissue containing the diet-responsive gene Nnat”, BMC Systems Biology 2010; vol. 4(175), pp. 1-11.
[cited by applicant]
Da Silva Lima, et al: “Modulatory effects of Guarana (
[cited by applicant]
Longo, et al: “Adipose tissue dysfunction as determinant of obesity-associated metabolic complications”, International Journal of Molecular Sciences; May 13, 2019; vol. 20, 2358; doi: 10.3390/ijms20092358.
[cited by applicant]
Lumeng, et al: “Obesity induces a phenotypic switch in adipose tissue macrophage polarization”, The Journal of Clinical Investigation; Jan. 2, 2007; vol. 117(1), pp. 175-184.
[cited by applicant]
Lynch, et al: “Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production”, Immunity; Sep. 21, 2012; vol. 37(3), pp. 574-587.
[cited by applicant]
Mahanta, et al: “Lower expression of GATA3 and T-bet correlates with downregulated IL-10 in severe falciparum malaria”, Clinical & Translational Immunology; Nov. 6, 2015; vol. 4, e49.
[cited by applicant]
Makki, et al: “Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines”, ISRN Inflammation; Dec. 22, 2013; vol. 2013; Article ID139239, 12 pages.
[cited by applicant]
McArdle, et al: “Mechanisms of obesity-induced inflammation and insulin resistance; insights into the emerging role of nutritional strategies”, Frontiers in Endocrinology; May 10, 2013; vol. 4(52), pp. 1-23.
[cited by applicant]
Meissburger, et al: “Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma”, EMBO Molecular Medicine 2011; vol. 3, pp. 637-651.
[cited by applicant]
Moseti, et al: “Molecular regulation of adipogenesis and potential anti-adipogenic bioactive molecules”, International Journal of Molecular Sciences; Jan. 19, 2016; vol. 17(124), pp. 1-24.
[cited by applicant]
Mota De Sa, et al: “Transcriptional regulation of adipogensis”, Comprehensive Physiology; Apr. 2017; vol. 7, pp. 635-674.
[cited by applicant]
Neels, et al: “Inflamed fat: what starts the fire?”, Journal of Clinical Investigation; Jan. 2006; vol. 116(1), pp. 33-35.
[cited by applicant]
Nomura, et al: “Pyrrothiogatain acts as an inhibitor of GATA family proteins and inhibits the Th2 cell differentiation in vitro”, Scientific Reports 2019; vol. 9(17335).
[cited by applicant]
Odegaard, et al: “Mechanisms of macrophage activation in obesity-induced insulin resistance”, Nat Clin Pract Endocrinol.; Nov. 2008; vol. 4(11), pp. 619-626.
[cited by applicant]
Odegaard, et al: “Type 2 responses at the interface between immunity and fat metabolism”, Curr Opin Immunol.; Oct. 2015; vol. 36, pp. 67-72.
[cited by applicant]
Okuno, et al: “Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese zucker rats”, Journal of Clinical Investigation; Mar. 1998; vol. 101(6), pp. 1354-1361.
[cited by applicant]
Ouyang, et al: “Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism”, Immunity; Nov. 1998; vol. 9, pp. 745-755.
[cited by applicant]
Pedroso, et al: “Inactivation of SOCS3 in leptin receptor-expressing cells protects mice from diet-induced insulin resistance but does not prevent obesity”, Molecular Metabolism; Jun. 12, 2014; vol. 3, pp. 608-618.
[cited by applicant]
Qiang, et al: “The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation”, Nature Communications; Apr. 26, 2016; DOI: 10.1038/ncomms11378.
[cited by applicant]
Radcke, et al: “A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes”, European Journal of Gastroenterology and Hepatology 2015; vol. 27(1), pp. 1-7.
[cited by applicant]
Rangwala, et al: “Genetic modulation of PPARy Phosphorylation regulates insulin sensitivity”, Developmental Cell; Oct. 2003; vol. 5, pp. 657-663.
[cited by applicant]
Ray, et al: “Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation”, The Journal of Clinical Investigation; Oct. 1999; vol. 104(8), pp. 985-993.
[cited by applicant]
Rochford, et al: “ETO/MTG8 is an inhibitor of C/EBPB activity and a regulator of early adipogenesis”, Molecular and Cellular Biology; Nov. 2004; vol. 24(22), pp. 9863-9872.
[cited by applicant]
Ryden, et al: “Transplanted bone marrow-derived cells contribute to human adipogenesis”, Cell Metabolism, Clinical and Translational Report; Sep. 1, 2015; vol. 22, pp. 408-417.
[cited by applicant]
Seki, et al: “IL-4-induced GATA-3 expression is a time-stricted instruction switch for Th2 cell differentiation”, The Journal of Immunology 2004; vol. 172, pp. 6158-6166.
[cited by applicant]
Sel, et al: “Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme”, Journal Allergy Clin Immunol; Mar. 6, 2008; vol. 121(4); pp. 910-916e.
[cited by applicant]
Sell, et al: “Adipose tissue inflammation: novel insight into the role of macrophages and lymphocytes”, Current Opinion in Clinical Nutrition and Metabolic Care 2010; vol. 13, pp. 366-370.
[cited by applicant]
Shi, et al: “A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells”, EMBO Reports; Mar. 14, 2003; vol. 4(4), pp. 374-380.
[cited by applicant]
Shin, et al: “Macrophage VLDLR mediates obesity-induced insulin resistance with adipose tissue inflammation”, Nature Communications 2017; vol. 8(1087); doi:10.1038/s41467-017-01232-w.
[cited by applicant]
Shoemaker, et al: “GATA-3 directly remodels the IL-10 Locus independently of IL-4 in CD4+ T Cells”, The Journal of Immunology 2006; vol. 176, pp. 3470-3479.
[cited by applicant]
Shulman, “Cellular mechanisms of insulin resistance”, Journal of Clinical Investigation 2000; vol. 106(2), pp. 171-176.
[cited by applicant]
Smith, et al: “Adipose tissue regulates insulin sensitivity: Role of adipogenesis, de novo lipogenesis and novel lipids”, Journal of Internal Medicine; Nov. 2016; vol. 280(5), pp. 465-475; doi:10.1111/joim. 12540.
[cited by applicant]
Snel, et al: “Ectopic fat and insulin resistance: Pathophysiology and effect of diet and lifestyle interventions”, International Journal of Endocrinology 2012; vol. 2012, Article ID 983814, 18 pages; doi: 10.1155/2012/9…
[cited by applicant]
Stefanon, et al: “Hydroxytyrosol, an ingredient of olive oil, reduces triglyceride accumulation and promotes lipolysis in human primary visceral adipocytes during differentiation”, Experimental Biology and Medicine 2016…
[cited by applicant]
Tencerova, et al: “Experimental hyperglycemia induces an increase of Monocyte and T-Lymphocyte content in adipose tissue of healthy obese women”, PLOS One, Apr. 20, 2015; vol. 10(3), e0122872.
[cited by applicant]
“The World Health Report 2002: Reducing Risks, Promoting Healthy Life”, World Health Organization; 230 pages.
[cited by applicant]
Tilg, et al: “Adipocytokines; mediators linking adipose tissue, inflammation and immunity”, Nature Reviews; Sep. 22, 2006; vol. 6, pp. 772-783.
[cited by applicant]
Tong, et al: “Function of GATA transcription factors in preadipocyte-adipocyte transition”, Science; Oct. 6, 2000; vol. 290, pp. 134-138.
[cited by applicant]
Tong, et al: “GATA transcription factors and fat cell formation”, Drug News & Perspectives 2003; vol. 16(9), p. 585.
[cited by applicant]
Tong, et al: “Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation”, Molecular and Cellular Biology; Jan. 2005; vol. 25(20, pp. 706…
[cited by applicant]
Tontonoz, et al: “Stimulation of adipogenesis in fibroblasts by PPARy2, a Lipid-activated transcription factor”, Cell; Dec. 30, 1994; vol. 79, pp. 1147-1156.
[cited by applicant]
Van Der Wijden, et al: “The relationship between moderate-to-vigorous intensity physical activity and insulin resistance, insulin-like growth factor (IGF-1)-system 1, leptin and weigth change in healthy women during pre…
[cited by applicant]
Van Esch, et al: “GATA3 haplo-insufficiency causes human HDR syndrome”, Letters to Nature, Jul. 27, 2000; vol. 406, pp. 419-422.
[cited by applicant]
Van Hamburg, et al: “Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology”, European Journal of Immunology 2008; vol. 38, pp. 2573-2586.
[cited by applicant]
Vigouroux, et al: “Molecular mechanisms of human lipodystrophies: From adipocyte lipid droplet to oxidative stress and lipotoxicity”, The International Journal of Biochemistry and Cell Biology; Mar. 8, 2011; vol. 43, pp…
[cited by applicant]
Villarroya, et al: “Toward an understanding of how immune cells control brown and beige adipobiology”, Cell Metabolism; May 1, 2018; vol. 27, pp. 954-961.
[cited by applicant]
Virtue, et al: “Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome—An allostatic perspective”, Biochimica Acta; Jan. 6, 2010; vol. 1801, pp. 338-349.
[cited by applicant]
Vishvanath, et al: “Contribution of antipogenesis to healthy adipose tissue expansion on obesity”, The Journal of Clinical Investigation; Review Series: Mechanisms Underlying The Metabolic Syndrome; Oct. 2019; vol. 129(…
[cited by applicant]
Wan, et al: “GATA3: a master of many trades in immune regulation”, Trends in Immunology, Cell Press; Jun. 2014; vol. 35(6), pp. 233-242.
[cited by applicant]
Wang, et al: “An essential role of the transcription factor GATA-3 for the function of regulatory T cells”, Immunity; Sep. 23, 2011; vol. 35(3), pp. 337-348.
[cited by applicant]
Wang, et al: “Wnt/B-catenin mediates AICAR effect to increase GATA3 expression and inhibit adipogenesis”, The Journal of Biological Chemistry; Aug. 7, 2015; vol. 290(32), pp. 19458-19468.
[cited by applicant]
Weisberg, et al: “Obesity is associated with macrophage accumulation in adipose tissue”, Journal of Clinical Investigations 2003; vol. 112, pp. 1796-1808.
[cited by applicant]
Wellen, et al: “Inflammation, stress, and diabetes”, The Journal of Clinical Investigation; May 2015; vol. 115(5), pp. 1111-1119.
[cited by applicant]
Wu, et al: “Cross-regulation of C/EBPa and PPARy controls the transcriptional pathway of adipogenesis and insulin sensitivity”, Molecular Cell; Feb. 1999; vol. 3, pp. 151-158.
[cited by applicant]
Xie, et al: “Interactive changes between macrophages and adipocytes”, Clinical and Vaccine Immunology; Apr. 2010; vol. 17(4), pp. 651-659.
[cited by applicant]
Xu, et al: “Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance”, Journal of Clinical Investigation 2003; vol. 112, pp. 1821-1830.
[cited by applicant]
Xu, et al: “GATA3, HDAC6, and BCL6 regulate FOX3P+ TREG Plasticity and determine TREG conversion into elthern novel and elantigen-presenting cell-like TREG or TH1-TREG”, Frontiers in Immunology; Jan. 26, 2018; vol. 9, A…
[cited by applicant]
Xue, et al: “Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome”, Diabetes Original Article; Mar. 2013; vol. 62, pp. 845-854.
[cited by applicant]
Yagi, et al: “An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation”, International Immunology; Jun. 1, 2011; vol. 23(7), pp. 415-420.
[cited by applicant]
Yamashita, et al: “Essential role of GATA3 for the maintenance of Type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine Gene
[cited by applicant]
Yang, et al: “Evidence of impaired adipogenesis in insulin resistance”, Biochemical and Biophysical Research Communications 2004; vol. 317, pp. 1045-1051.
[cited by applicant]
Yang, et al: “Pathological conditions re-shape physiological Tregs into pathological Tregs”, Burns & Trauma 2105; vol. 3(1), pp. 1-11.
[cited by applicant]
Zeitvogel, et al: “GATA3 regulates FLG and FLG2 expression in human primary keratinocytes”, Scientific Reports; Sep. 19, 2017; vol. 7, 11847, 11 pages.
[cited by applicant]
Al-Sulaiti, et al: “Mediators of impaired adipogenesis in obesity-associated insulin resistance and T2DM”, IntechOpen, Adipose Tissue—An Update; pp. 1-26; doi:http://dx.doi.org/10.5772/intechopen.88746.
[cited by applicant]
Al-Sulaiti, et al: “Metabolic signature of obesity-associated insulin resistance and type 2 diabetes”, Journal of Translational Medicine 2019; vol. 17(348), pp. 1-11.
[cited by applicant]
Al-Sulaiti, et al: “Triglyceride proffling in adipose tissues from obese insulin sensitive, insulin resistant and type 2 diabetes mellitus individuals”, Journal of Translational Medicine 2018; vol. 16(175), pp. 1-13.
[cited by applicant]
Almuraikhy, et al: “Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance”, Diabetologia; Jun. 24, 2016: vol. 59, pp. 2406-2416.
[cited by applicant]
Asch-Kendrick, et al: The role of GATA3 in breast carcinomas: A Review:, Human Pathology 2015, doi: 10.1016/j.humanpath.2015.09.035.
[cited by applicant]
Batchvarova, et al: “Inhibition of adipogenesis by the stress-induced protein CHOP (Gadd153)”, The EMBO Journal 1995; vol. 14(19), pp. 4654-4661.
[cited by applicant]
Bezy, et al: “Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding Protein B Implicated in Adipocyte differentiation”, The Journal of Biological Chemistry; Mar. 25, 2005; vol. 280(12), pp. 114…
[cited by applicant]
Blokzijl, et al: “Physical and functional interaction between GATA-3 and Smad3 allows TGF-Regulation of GATA Target Genes”, Current Biology; Jan. 8, 2002; vol. 12, p. 35-45.
[cited by applicant]
Burzyn, et al: “Regulatory T Cells in non-lymphoid tissues”, Nat Immunol.; Oct. 2013; vol. 14(10), pp. 1007-1013.
[cited by applicant]
Cancello, et al: “Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity”, Diabetes; Jun. 2006; vol. 55, pp. 1554-1561.
[cited by applicant]
Cao, et al: “Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells”, Genes & Development 1991; vol. 5, pp. 1538-1552.
[cited by applicant]
Cao, et al: “Yeast B-glucan suppresses the chronic inflammation and improves the microenvironment in adipose tissues of ob/ob mice”, Journal of Agricultural and Food Chemistry; Dec. 29, 2017; doi: 10.1021/acs.jafc.7b049…
[cited by applicant]
Cawthorn, et al: “Adipose tissue stem cells meet preadipocyte commitment: going back to the future”, Journal of Lipid Research 2012; Dec. 1, 2011; vol. 53, pp. 227-246.
[cited by applicant]
Cawthorn, et al: “Tumour necrosis factor-a inhibits adipogenesis via a B-catenin/TCF4(TCF7L2)-dependent pathway”, Cell Death Differ., Jul. 2007; vol. 14(7), pp. 1361-1373.
[cited by applicant]
Chen, et al: “GATA3 as master regulator and therapeutic target in ovarian high-grade serous carcinoma stem cells”, International Journal of Cancer, Jul. 14, 2018; https://doi.org/10.1002/ijc.31750.
[cited by applicant]
Chen, et al: “Mature miR-183, negatively regulated by transcription factor GATA3, promotes 3T3-L1 adipogenesis through inhibition of the canonical Wnt/B-catenin signaling pathway by targeting LRP6”, Cellular Signalling;…
[cited by applicant]
Chen, et al: “Mechanisms linking inflammation to insulin resistance”, International Journal of Endocrinology 2015; vol. 2015, Article ID 508409, 9 pages.
[cited by applicant]
Chen, et al: “Treatment of allergic inflammation and hyperresponsiveness by a simple compound, Bavachinin, isolated from Chinese herbs”, Cellular & Molecular Immunology; Sep. 9, 2013; vol. 10, pp. 497-505.
[cited by applicant]
Cho, et al: “Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance”, J. Immunol; Nov. 1, 2016; vol. 197(9), pp. 3650-3661.
[cited by applicant]
Choe, et al: “Adipose tissue remodeling: Its role in energy metabolism and metabolic disorders”, Frontiers in Endocrinology; Apr. 13, 2016; vol. 7, Article 30.
[cited by applicant]
Choe, et al: “Macrophage HIF-2a ameliorates adipose tissue inflammation and insulin resistance in obesity”, Diabetes; Oct. 2014; vol. 63, pp. 3359-3371.
[cited by applicant]
Cipolletta, et al: “PPARy is a major driver of the accumulation of phenotype of adipose tissue T reg Cells”, Nature, Jun. 28, 2012; vol. 486(7404), pp. 549-553.
[cited by applicant]
Colitti, et al: “Different anti-adipogenic effects of bio-compounds on primary visceral pre-adipocytes and adipocytes”, EXCLI Journal; Jun. 20, 2016; vol. 15, pp. 362-377.
[cited by applicant]
Derosa, et al: “Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetesmellitus? Role of markErs in the progresSion of Dlabetes in obese paTieNts (The RESISTIN tria…
[cited by applicant]
Dubois, et al: “Decreased expression of adipogenic genes in obese subjects with Type 2 diabetes”, Obesity (Silver Spring); Sep. 2006; vol. 14(9), pp. 1543-1552.
[cited by applicant]
El Arabey, et al: “GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma”, Cellular Signalling; Jan. 11, 2020; vol. 68, Article 109539.
[cited by applicant]
Elrayess, et al: “4-hydroxynonenal causes impairment of human subcutaneous adipogenesis and induction of adipocyte insulin resistance”, Free Radical Biology & Medicine 2017; Author's Accepted Manuscript, http://dx.doi.o…
[cited by applicant]
Farmer, “Transciptional control of adipocyte formation”, Cell Metabolism; Oct. 2006; vol. 4, pp. 263-273.
[cited by applicant]
Ferber, et al: “GATA-3 significantly downregulates IFN-y production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels”, Clinical Immunology; May 1999; vol. 91(2), pp. 134-144.
[cited by applicant]
Feuerer, et al: “Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters”, Nature Medicine; Jul. 26, 2009; vol. 15(8), pp. 930-940.
[cited by applicant]
Fokina, et al: “DNA enzymes as potential therapeutics: Towards clinical application of 10-23 DNAzymes”, Expert Opinion on Biological Therapy; Mar. 14, 2015; vol. 15, No. 5, pp. 689-711.
[cited by applicant]
Frieler, et al: “Nuclear receptor control of opposing macrophagephenotypes in cardiovascular disease”, Frontiers in Bioscience; Jan. 1, 2012; vol. 17, pp. 1917-1930.
[cited by applicant]
Garn, et al: “GATA-3-specific DNAzyme—a novel approach for stratified asthma therapy”, European Journal of Immunology 216; doi: 10.1002/eji.201646450.
[cited by applicant]
Ghonim, et al: “PARP is activated in human asthma and its inhibition of olaparib blocks house dust mite-induced disease in mice”, Clinical Science 2015; vol. 129, pp. 951-962.
[cited by applicant]
Gregoire, et al: “Understanding adipocyte differentiation”, Physiological Reviews; Jul. 1998; vol. 78(3), pp. 783-809.
[cited by applicant]
Goossens, et al: “Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans”, Molecular Immunology 2012; vol. 50, p…
[cited by applicant]
Grundy, et al: “Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition; NHLBI/AHA Proceedings”, Arterio…
[cited by applicant]
Guan, et al: “GATA binding protein 3 is correlated with leptin regulation of PPARy1 in hepatic stellate cells”, J. Cell. Mol. Med. 2017; vol. 21(3), pp. 568-578.
[cited by applicant]
Guilherme, et al: “Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes”, Nat. Rev. Mol. Cell Biol.; May 2008; vol. 9(5), pp. 367-377.
[cited by applicant]
Gupta, et al: “Transciptional control of preadipocyte determination by Zfp423”, Nature Letters; Mar. 2010, vol. 464, pp. 619-625.
[cited by applicant]
Gustafson, et al: “Insulin resistance and impaired adipogenesis”, Cell Press Review; Apr. 2015; vol. 26(4), pp. 193-200.
[cited by applicant]
Ham, et al: “Macrophage Glucose-6-Phosphate Dehydrogenase stimulates proinflammatory responses to oxidative stress”, Molecular and Cellular Biology; Jun. 2013; vol. 33(12), pp. 2425-2435.
[cited by applicant]
Hammarstedt, et al: “WISP2 regulates preadipocyte commitment and PPARy activation by BMP4”, PNAS; Feb. 12, 2013; vol. 110(7), pp. 2563-2568.
[cited by applicant]
Han, et al: “IL-33 Reverses an obesity-induced deficit in visceral adipose tissue ST2+ T Regulatory cells and Ameliorates adipose tissue inflammation and insulin resistence”, The Journal of Immunology; Apr. 13, 2015; vo…
[cited by applicant]
Hauner: “The new concept of adipose tissue function”, Physiology & Behavior 2004; vol. 83, pp. 653-658.
[cited by applicant]
Helaleh, et al: “Association of polybrominated diphenyl ethers in two fat compartments with increased risk of insulin resistance in obese individuals”, Chemosphere; Jun. 18, 2018; vol. 209, pp. 268-276.
[cited by applicant]
Ho, et al: “GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation”, Nat Rev Immunol; Feb. 2009; vol. 9(2), pp. 125-135.
[cited by applicant]
Hocking, et al: “Adiposity and insulin resistance in humans: The role of the different tissue and cellular lipid depots”, Endocrine Reviews; Apr. 2, 2013; vol. 34(4), pp. 463-500.
[cited by applicant]
Homburg, et al: “Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with Th2-driven asthma”, Letter to the Editor, J. Allergy Clin Immunol 2015; http://dx.doi.org/10.1016/j.jaci.2015.02.…
[cited by applicant]
Hong, et al: “The ethanol extract of Holotrichia diomphalia larvae, containing fatty acides and amino acids, exerts anti-asthmatic effects through inhibition of the GATA-3/Th2 Signaling pathway in asthmatic mice”, Molec…
[cited by applicant]